Treatment method using EGFR antibodies and src inhibitors and related formulations

Details for Australian Patent Application No. 2008227123 (hide)

Owner Ludwig Institute for Cancer Research

Inventors Furnari, Frank; Johns, Terrance Grant; Cavenee, Webster; Scott, Andrew

Agent Spruson & Ferguson

Pub. Number AU-A-2008227123

PCT Pub. Number WO2008/115404

Priority 60/918,084 15.03.07 US

Filing date 14 March 2008

Wipo publication date 25 September 2008

International Classifications

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

8 October 2009 PCT application entered the National Phase

  PCT publication WO2008/115404 Priority application(s): WO2008/115404

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008227127-Anti-unscrewing and multi-angular fastening apparatuses and methods for surgical bone screw/plate systems

2008227120-Method and apparatus for feedback overhead reduction in wireless communications